Postpartum hemorrhage due to uterine atony is the primary direct cause of maternal mortality globally. Management strategies in developed countries involve crystalloid fluid replacement ...

Although the European Medicines Agency (EMA) recently approved a recombinant FVIIa (rFVIIa) for the treatment of acute bleeding in postpartum hemorrhage (PPH), its use is associated with risks of ...

Effective solutions to tackle postpartum bleeding need ... are two types of PPH. Primary postpartum haemorrhage occurs within the first 24 hours after delivery. However, secondary or late ...